1
James Aggen, John H Griffin, Mathai Mammen, Daniel Marquess, Edmund J Moran, David Oare: Muscarinic receptor antagonists. Theravance, Jeffrey A Hagenah, Joyce G Cohen, February 17, 2004: US06693202 (123 worldwide citation)

Disclosed are multibinding compounds which are muscarinic receptor antagonists. The multibinding compounds of this invention containing from 2 to 10 ligands covalently attached to one or more linkers. Each ligand is, independently of each other, a muscarinic receptor antagonist or an allosteric modu ...


2
Mathai Mammen, David Oare: Therapeutic ureas. Theravance, Jeffrey A Hagenah, David E Boone, October 21, 2003: US06635764 (76 worldwide citation)

This invention relates to urea compounds that are muscarinic receptor antagonists and agonists, pharmaceutical compositions comprising such compounds, and methods of preparing these compounds.


3
Mathai Mammen, Sarah Dunham, Adam Hughes, Tae Weon Lee, Craig Husfeld, Eric Stangeland, Yan Chen: Biphenyl derivatives. Theravance, Jeffrey A Hagenah, November 28, 2006: US07141671 (64 worldwide citation)

This invention provides biphenyl derivatives of formula I: wherein R1, R2, R3, R4, R5, R6, R7, W, a, b and c are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The biphenyl derivatives of this invention possess both β2 adrenergic receptor a ...


4

5
Edmund J Moran, Seok Ki Choi: &bgr;2-adrenergic receptor agonists. Theravance, David E Boone, Jeffrey A Hagenah, Roberta P Saxon, April 1, 2003: US06541669 (54 worldwide citation)

Disclosed are multibinding compounds which are &bgr;2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.


6
Edmund J Moran, John H Griffin, Seok Ki Choi: &bgr;2-adrenergic receptor agonists. Theravance, David E Boone, Jeffrey A Hagenah, Roberta P Saxon, June 10, 2003: US06576793 (48 worldwide citation)

Disclosed are multibinding compounds which are &bgr;2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma and bronchitis. They are also useful in the treatment of nervous system injury and premature labor.


7
Saito Daisuke Roland, Long Daniel D, Jacobsen John R: Disubstituted alkyl-8-azabicyclo [3.2.1.] octane compounds as mu opioid receptor antagonists. Theravance, Saito Daisuke Roland, Long Daniel D, Jacobsen John R, HAGENAH Jeffrey A, March 5, 2009: WO/2009/029257 (48 worldwide citation)

The invention provides novel 8-azabicyclo[3.2.1]octane compounds of formula (I), where the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are antagonists at the mu opioid receptor. The invention also provides pharmaceutical compositions comprising suc ...


8

9
Mammen Mathai, Hughes Adam: Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity. Theravance, Mammen Mathai, Hughes Adam, HAGENAH Jeffrey A, October 21, 2004: WO/2004/089892 (46 worldwide citation)

This invention provides compounds of formula I: wherein R1, R2, R3, R4, R5, R6, R7, Ar1, Ar2, E, a, b, c, and z are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The compounds of this invention possess both &bgr;2 adrenergic receptor agoni ...


10


Click the thumbnails below to visualize the patent trend.